Debunking insurer health trend rates
There’s been no shortage of recent studies indicating that for the past few years, prescription drug inflation in Canada has been relatively flat. Drug patent…
- July 23, 2014 September 13, 2019
- 10:30
There’s been no shortage of recent studies indicating that for the past few years, prescription drug inflation in Canada has been relatively flat. Drug patent…
John is a 44-year-old father of two, and a lending officer at a branch of a national bank. Early on in his career, John’s branch…
It’s hard to pick up a newspaper without someone referencing the fact that many stock markets are at their all-time highs. The S&P 500 Index…
How many regulators does it take to ensure that Canadian employment pensions are prudently funded and properly administered? Answer: 11—one to actually regulate pensions and…
Why they might have trouble gaining a foothold.
I recently attended CPBI’s Forum in Boston. A theme that emerged loud and clear from the majority of the speakers on the topic of benefits…
There have been seven new drug products brought to market already in 2014 in Canada (excluding influenza vaccine formulations), five of which are specialty drugs.…
Goldman Sachs says Brazil's going to win the game and so is its stock market.
New paper says it's all about demand shocks.
Hint: it's not about style or factors.
New paper exposes how haphazard our estimates really are.
One size no longer fits all and employees are demanding benefits that cater to their unique needs. Twenty years ago most organizations provided traditional benefits…
Investors assumptions about what ETFs are and aren't have changed radically in a short time.